Literature DB >> 5506105

Criteria for internal mammary artery implantation based on cine coronary arteriography.

M G Bourassa, J Lespérance, Y Castonguay, L Campeau, J Saltiel.   

Abstract

Preoperative coronary arteriograms were correlated, in a group of 50 patients, with left internal mammary angiograms obtained from 11 to 32 months, with a mean of 17 months, after mammary artery implantation. In all patients in whom the internal mammary artery was patent and considered functional with good angiographic opacification of the anterior descending coronary artery, the preoperative coronary angiogram showed total or subtotal obstruction of the latter vessel, with indirect evidence of decreased flow and pressure distal to the obstruction. This evidence was provided by the presence of a collateral circulation or, in a few cases of subtotal obstruction, delayed opacification of the vessel distal to the obstruction.In patients in whom the internal mammary artery was patent but showed no anastomotic connection with the anterior descending coronary artery or only opacification of small coronary branches, the degree of coronary obstruction was, in most cases, less than 90% of the lumen of the coronary artery in the absence of any collateral circulation or delayed opacification of the vessel distal to the obstruction.Occlusion of the internal mammary artery was seen as often in the presence of total or subtotal obstructions as with lesser degrees of anterior descending coronary artery obstruction, and is believed unrelated to the degree of pre-existing coronary artery disease.Successful internal mammary artery implantation can be related to specific coronary angiographic patterns recognizable before operation; these may serve as reliable criteria for the selection of patients.

Entities:  

Mesh:

Year:  1970        PMID: 5506105      PMCID: PMC1930573     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  10 in total

1.  Hemodynamic effects of arterial stenosis.

Authors:  A G MAY; J A DE WEESE; C G ROB
Journal:  Surgery       Date:  1963-04       Impact factor: 3.982

2.  Experience with a new electro-magnetic flow-meter for use in blood-flow determinations in surgery.

Authors:  J A CANNON; E L LOBPREIS; G HERROLD; H L FRANKENBERG
Journal:  Ann Surg       Date:  1960-10       Impact factor: 12.969

3.  Hemodynamics of experimental coarctation of the aorta.

Authors:  W G SCHENK; A D MENNO; J W MARTIN
Journal:  Ann Surg       Date:  1961-02       Impact factor: 12.969

4.  Clinical significance of selective coronary cinearteriography.

Authors:  L Campeau; M G Bourassa; M A Bois; J Saltiel; J Lesperance; O Rico; J L Delcan; M Telleria
Journal:  Can Med Assoc J       Date:  1968-12-07       Impact factor: 8.262

5.  Myocardial revascularization by Vineberg's internal mammary artery implant. Evaluation of postoperative results.

Authors:  D B Effler; F M Sones; L K Groves; E Suarez
Journal:  J Thorac Cardiovasc Surg       Date:  1965-10       Impact factor: 5.209

6.  Selective cine coronary arteriography. Correlation with clinical findings in 1,000 patients.

Authors:  W L Proudfit; E K Shirey; F M Sones
Journal:  Circulation       Date:  1966-06       Impact factor: 29.690

7.  Selective revascularization of the myocardium by internal-mammary-artery implant.

Authors:  R Gorlin; W J Taylor
Journal:  N Engl J Med       Date:  1966-08-11       Impact factor: 91.245

8.  Direct measurement of extracoronary blood flow after revascularization procedures.

Authors:  R L Criollos; A M AlShamma; B B Roe
Journal:  Ann Thorac Surg       Date:  1967-08       Impact factor: 4.330

9.  Factors responsible for success of the Vineberg operation. An experimental study.

Authors:  C H Sparks
Journal:  Ann Thorac Surg       Date:  1967-05       Impact factor: 4.330

10.  Flowmeter studies of internal mammary artery function after implantation into the left ventricular myocardium.

Authors:  J L Provan; G L Hammond; W G Austen
Journal:  J Thorac Cardiovasc Surg       Date:  1966-12       Impact factor: 5.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.